Giovanni Coticchio , Danilo Cimadomo , Laura Rienzi
{"title":"Do we still need embryologists?","authors":"Giovanni Coticchio , Danilo Cimadomo , Laura Rienzi","doi":"10.1016/j.rbmo.2024.104790","DOIUrl":null,"url":null,"abstract":"<div><div>IVF has given scientists a unique role, one probably unparalleled in other medical disciplines. This role has become increasingly more impactful due to the introduction of breakthrough laboratory interventions, such as intracytoplasmic sperm injection and cryopreservation. More recently, incessant advances in automation, information technology and artificial intelligence have started to transform diverse biomedical disciplines. In IVF, relevant examples are novel equipment that can automatically perform embryo assessment, patient/sample identification, vitrification and sperm manipulation/selection/analysis. This has questioned the role of the embryologist. However, the introduction of novel technology is not straightforward; it generates numerous challenges. Which manual interventions should be automated and why? Do machines perform better than humans? Does automation involve higher treatment costs? At the same time, certain highly intellectual activities, such as the integration of novel categories of data and their interpretation, formulation of novel key performance indicators, generation of novel educational and training contents and enhancement and collaborative research, remain human prerogatives. Therefore, while it is to be expected that direct human intervention will be partly replaced by automated devices, we can envisage that the embryologist's role will not become extinct, but will evolve in new forms. Ideally, this change should be guided by principles safeguarding the ethics of medicine and human activity.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"50 4","pages":"Article 104790"},"PeriodicalIF":3.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive biomedicine online","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1472648324009799","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
IVF has given scientists a unique role, one probably unparalleled in other medical disciplines. This role has become increasingly more impactful due to the introduction of breakthrough laboratory interventions, such as intracytoplasmic sperm injection and cryopreservation. More recently, incessant advances in automation, information technology and artificial intelligence have started to transform diverse biomedical disciplines. In IVF, relevant examples are novel equipment that can automatically perform embryo assessment, patient/sample identification, vitrification and sperm manipulation/selection/analysis. This has questioned the role of the embryologist. However, the introduction of novel technology is not straightforward; it generates numerous challenges. Which manual interventions should be automated and why? Do machines perform better than humans? Does automation involve higher treatment costs? At the same time, certain highly intellectual activities, such as the integration of novel categories of data and their interpretation, formulation of novel key performance indicators, generation of novel educational and training contents and enhancement and collaborative research, remain human prerogatives. Therefore, while it is to be expected that direct human intervention will be partly replaced by automated devices, we can envisage that the embryologist's role will not become extinct, but will evolve in new forms. Ideally, this change should be guided by principles safeguarding the ethics of medicine and human activity.
期刊介绍:
Reproductive BioMedicine Online covers the formation, growth and differentiation of the human embryo. It is intended to bring to public attention new research on biological and clinical research on human reproduction and the human embryo including relevant studies on animals. It is published by a group of scientists and clinicians working in these fields of study. Its audience comprises researchers, clinicians, practitioners, academics and patients.
Context:
The period of human embryonic growth covered is between the formation of the primordial germ cells in the fetus until mid-pregnancy. High quality research on lower animals is included if it helps to clarify the human situation. Studies progressing to birth and later are published if they have a direct bearing on events in the earlier stages of pregnancy.